TY - CHAP M1 - Book, Section TI - Travel Health A1 - Slain, Douglas A1 - Kincaid, Scott A2 - DiPiro, Joseph T. A2 - Yee, Gary C. A2 - Posey, L. Michael A2 - Haines, Stuart T. A2 - Nolin, Thomas D. A2 - Ellingrod, Vicki Y1 - 2020 N1 - T2 - Pharmacotherapy: A Pathophysiologic Approach, 11e AB - KEY CONCEPTS Travelers should consult practitioners with travel health expertise when going to tropical or developing countries. For the pretravel consultation recommendations, travelers should be given written material in their language to reinforce and supplement verbal instructions. The pretravel screening appointment should include a discussion of items that should be contained in a travel medical kit. Pregnant travelers should consult obstetric and travel medicine experts prior to traveling to developing countries. Immunocompromised patients may need longer periods of pretravel preparatory time to allow for adequate immunization, given their sometimes blunted antibody responses to vaccines. Travelers to sub-Saharan Africa, Southern Asia, Central and South America, and the Caribbean experience higher rates of infection than those traveling to other parts of the world. Prophylactic antibiotic use may reduce the risk of traveler’s diarrhea but is generally not recommended, primarily because of the risk of developing drug resistance or Clostridium difficile infection. Prevention strategies are essential for limiting vector-borne infections during travel. The mainstay of therapy in all altitude-related illnesses is descent to a lower altitude (typically at least a 300-meter reduction in altitude). Patients who have previously been diagnosed with depression should continue their prescribed medications and minimize alcohol consumption while traveling. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1182426234 ER -